Compounds > nafamostat
Page last updated: 2024-10-31

nafamostat and Marchiafava-Micheli Syndrome

nafamostat has been researched along with Marchiafava-Micheli Syndrome in 1 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamamura, M1

Other Studies

1 other study available for nafamostat and Marchiafava-Micheli Syndrome

ArticleYear
Open heart surgery in a patient with paroxysmal nocturnal hemoglobinuria.
    The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi, 2005, Volume: 53, Issue:6

    Topics: Aged; Benzamidines; Complement Inactivator Proteins; Coronary Artery Bypass, Off-Pump; Female; Guani

2005